Orion Oyj (ORINF) Q1 2026 Earnings Call Highlights: Robust Growth and Strategic Outlook [Yahoo! Finance]
ORION CORP NEW UNSP/ADR (ORINY)
NASDAQ:AMEX Investor Relations:
orion.fi/en/orion-group/investors/investor-relations
Company Research
Source: Yahoo! Finance
Operating Profit Growth: 47% increase, leading to an operating profit margin of 27.5%. Earnings Per Share: Increased by 47%. Innovative Medicines Division Growth: Close to 54% growth. Nubeqa Royalties and Tablet Sales: Approximately EUR145 million. Branded Products Growth: Close to 7%, reaching EUR82.2 million. Generics and Consumer Health Growth: 1.4% growth. Animal Health Growth: 3.3% growth. Top 10 Products: Nubeqa, Easyhaler (7% growth), Entacapone, Dexdomitor, Women's Health (15% growth). Sustainability - Greenhouse Gas Emissions: Decreased by 13% (Scope 1 and 2). Outlook Adjustment: Increased lower limit of net sales range to EUR1.95 billion and operating profit to EUR600 million. Warning! GuruFocus has detected 5 Warning Signs with ORINF. Is ORINF fairly valued? Test your thesis with our free DCF calculator. Release Date: April 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Point
Show less
Read more
Impact Snapshot
Event Time:
ORINY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORINY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORINY alerts
High impacting ORION CORP NEW UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ORINY
News
- Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDAGlobeNewswire
- Does Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy? [Yahoo! Finance]Yahoo! Finance
- Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Developments [Yahoo! Finance]Yahoo! Finance
- The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company's key persons [Yahoo! Finance]Yahoo! Finance
- Notice to the Annual General Meeting of Orion Corporation [Yahoo! Finance]Yahoo! Finance